Limb Sparing Surgery with Vascular reconstruction in lower extremity soft tissue Sarcoma: Promising results
There is uncertainty within the literature as to whether major vessel involvement
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
There is uncertainty within the literature as to whether major vessel involvement
efficacy of sequential administration of trabectedin and nivolumab in patients with advanced soft tissue sarcoma (STS). Methodology: 14 patients with metastatic STS were evaluated. Each patient received one dose
BACKGROUND Soft tissue sarcomas (STS) account for less than 1% of all malignant tumours but present a significant diagnostic and therapeutic challenge since there are more than 50 histological subtypes.1…
Soft tissue sarcomas are always challenging lesions. This study is aimed to stress on unusual presentation of sarcoma patients that may cause significant delay in the diagnosis to provide appropriate ... cases of…
Soft tissue sarcoma is a rare type of cancer that arises in the soft tissues of the body, and when it occurs in the extremities, it presents unique challenges ... treatment. This article provides an overview of the…
Soft tissue sarcomas (STS) are group of rare tumors arising from mesenchymal tissues. It can develop in soft tissues like skeletal muscle, fibrous tissue, fat, nerves, blood vessels, lymphatic vessels ... internal…
undergo surgery. We give the ifosfamide, mesna and etoposide regimen for the soft tissue sarcoma. After 3 cycles, evaluated imaging MSCT have done and the lump disappeared, there ... called multiple primary malignant…
Soft tissue sarcoma (STS) is a rare and diverse group of malignancies originating from soft tissues, presenting significant challenges in diagnosis and treatment. However, recent advancements in STS research
being diagnosed with malignancies. We aimed to investigate the outcomes of patients with soft tissue sarcomas who underwent unplanned excisions of their tumors followed by additional excisions at our institution…
Soft tissue sarcoma (STS) encompasses a diverse group of rare and challenging malignancies originating from soft tissues. Historically, treatment options have been limited to surgery, radiation, and chemotherapy, often…
been proposed as an essential factor in the staging of patients with soft tissue sarcomas. Histopathologic grading by French Federation of Cancer Centres (FNCLCC) is widely accepted and applicable ... types of soft…
antitumor drugs to soft tissue sarcoma (STS) have been approved, clinical data about the patterns of treatment of STS patients were reported from many Western countries, but those from Asia
dosage of pazopanib in Japanese patients with metastatic or unresectable advanced soft tissue sarcoma. Methods: Subjects were 42 patients (16 men and 26 women) with a history of previous anti ... cancer agent treatment…
Introduction: Soft tissue sarcomas are malignant tumors that require management in specialized centers. The aim of our study is to evaluate the benefit of the multidisciplinary meeting ... literature one with respect to…
uncertainty in the literature as to whether major vessel involvement in extremity soft tissue sarcomas constitutes an indication for amputation. This prospective study includes fifteen patients with lower extremity soft…
types. Therapeutic drugs have been shown to promote differentiation in preclinical models including soft tissue sarcomas (STS) that often resemble undifferentiated mesenchymal tissues. Rhabdomyosarcomas (RMS) are the…
Background: Soft tissue sarcomas (STS) are rare and biologically heterogeneous malignant mesenchymal tumors characterized by diverse histological subtypes, a high propensity for local recurrence, and the potential for…
Soft tissue sarcomas represent a rare but histologically variable type of solid malignancy. Doxorubicin based regimens either alone or in combination with other agents had remained unchanged for decades
this study was to correlate MVT use with survival in patients with soft tissue sarcomas (STS). Materials and methods: Between 2000-2012, 185 patients with stage I-III STS underwent
Vodanovich DA*, Spelman T, May D, Slavin J, Choong PFM PDF Share
Pallavi A Patil, Kara Lombardo, Ashlee Sturtevant, Shamlal Mangray and Evgeny Yakirevich
uncertainty in the literature as to whether major vessel involvement in extremity soft tissue sarcomas constitutes an indication for amputation. This prospective study includes fifteen patients with lower extremity soft…
For authors and organisers
Find the right journal for your paper and submit your manuscript.